BEONE MEDICINES LTD. Revenue from Contract with Customer, Including Assessed Tax
BEONE MEDICINES LTD. (ONC) reported Revenue from Contract with Customer, Including Assessed Tax of $387.63 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2022-11-09
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for the quarter ending 2022-09-30 was $387.63M, a 87.77% increase year-over-year.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for the quarter ending 2022-06-30 was $341.57M, a 127.73% increase year-over-year.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for the quarter ending 2022-03-31 was $306.63M, a 49.39% decline year-over-year.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for the quarter ending 2021-12-31 was $213.98M.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for fiscal 2021 was $1.18B, a 280.83% increase from fiscal 2020.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for fiscal 2020 was $308.87M, a 27.87% decline from fiscal 2019.
- BEONE MEDICINES LTD. revenue from contract with customer, including assessed tax for fiscal 2019 was $428.21M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2022-09-30 | $387.63M 10-Q · filed 2022-11-09 | $729.20M derived: sum of 2 quarters · filed 2022-11-09 | $1.04B 10-Q · filed 2022-11-09 | $1.25B derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $341.57M 10-Q · filed 2022-08-08 | $648.20M 10-Q · filed 2022-08-08 | $862.18M derived: sum of 3 quarters · filed 2022-08-08 | $1.07B derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $306.63M 10-Q · filed 2022-05-09 | $520.61M derived: sum of 2 quarters · filed 2022-05-09 | $727.04M derived: sum of 3 quarters · filed 2022-11-09 | $877.04M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $213.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $420.42M derived: sum of 2 quarters · filed 2022-11-09 | $570.41M derived: sum of 3 quarters · filed 2022-11-09 | $1.18B 10-K · filed 2022-02-28 |
| 2021-09-30 | $206.44M 10-Q · filed 2022-11-09 | $356.43M derived: sum of 2 quarters · filed 2022-11-09 | $962.30M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $149.99M 10-Q · filed 2022-08-08 | $755.86M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $605.87M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $308.87M 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $428.21M 10-K · filed 2022-02-28 |